Optimizing Flumatinib Therapy in Chinese Chronic-Phase Chronic Myeloid Leukemia Based on Therapeutic Drug Monitoring
Drug Design, Development and Therapy · 2026-06 · Volume 20 · 1-10
DOI: 10.2147/dddt.s612207 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026-06. Verfasst von Fang Cheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074, Hubei, Pe…. Hauptthemen laut MEDLINE: Aminopyridines, Antineoplastic Agents, Benzamides, Drug Monitoring. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074, Hubei, People's Republic of China.
- Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
- Department of Hematology, Suizhou Hospital, Hubei University of Medicine, Suizhou, 441300, Hubei, People's Republic of China.
- Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
Zitieren
APA
Cheng, F., Wang, F., Cui, Z., Li, Q., Liu, X., & Li, W. (2026). Optimizing Flumatinib Therapy in Chinese Chronic-Phase Chronic Myeloid Leukemia Based on Therapeutic Drug Monitoring. Drug Design, Development and Therapy, Volume 20, 1-10. https://doi.org/10.2147/dddt.s612207
Vancouver
Cheng F, Wang F, Cui Z, Li Q, Liu X, Li W. Optimizing Flumatinib Therapy in Chinese Chronic-Phase Chronic Myeloid Leukemia Based on Therapeutic Drug Monitoring. Drug Design, Development and Therapy. 2026;Volume 20:1-10. doi:10.2147/dddt.s612207
BibTeX
@article{Cheng2026,
author = {Cheng, Fang and Wang, Fan and Cui, Zheng and Li, Qiang and Liu, Xin and Li, Weiming},
title = {Optimizing Flumatinib Therapy in Chinese Chronic-Phase Chronic Myeloid Leukemia Based on Therapeutic Drug Monitoring},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--10},
doi = {10.2147/dddt.s612207}
}
EUVIMED